CSL’s Graduate Program in Australia recently welcomed 14 top students who will take on real projects with real responsibilities during three, eight-month rotations in the global business.
The program is designed to provide broad opportunities that allow the graduates to develop business skills and deepen their understanding CSL’s work delivering on its promise to patients worldwide. CSL, a leading biotech company, specializes in medicines for rare and serious diseases and is one of the world’s largest providers of influenza vaccine.
The graduates receive on-the-job technical training, structured coaching and regular performance feedback, specialist development activities and mentoring from CSL’s senior leaders. During their virtual orientation week, the graduates attended workshops and met CSL leaders, including Chief Financial Officer Joy Linton and CEO and Managing Director Paul Perreault.
Perreault said the graduates are highly driven, innovative and tech-savvy.
“It was really pleasing to spend time with the group earlier this year to welcome them to CSL, share our values and business priorities, and provide them with the support to set them up for success as they make their transition into the workforce,” he said.
CSL’s program is ranked on two lists: GradConnection and GradAustralia, where it is No. 2 in the R&D sector.
Joining the business are:
- Daniel Siddiqui, Engineering, CSL Behring
- Tom Shembrey, Engineering, CSL Behring
- Holly Obelt, Quality, CSL Behring
- Alicia Cayayan, Quality, CSL Behring
- Anthea Wainwright, Commercial Operations, CSL Behring
- Tom Siedle, Supply Chain, CSL Behring
- Anthony Stoikos, Global Procurement, CSL Behring
- Annika Allen, Global Procurement, CSL Behring
- Tony Tawk, Finance, CSL Ltd
- Erin Chapman, Manufacturing, Seqirus
- Rebecca Ong, Manufacturing, Seqirus
- David Ho, Manufacturing, Seqirus
- Eliza Maher, Quality, Seqirus
- Ethan Ward, Commercial Operations, Seqirus
